Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin and its effect on heart failure in type 2 diabetes
DRKS00009894Phase 4Completed
- Sponsor
- Universitätsklinikum Freiburg
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) and heart failure (HF) comparing Empagliflozin arm with Placebo arm (2 arms). Started Nov 2016; status: completed.
02
Drugs
empagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)heart failure (HF)
Beyond the preview
Go deeper on DRKS00009894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00009894.